What Are the Causes of Depression? The Neuroscience Behind Persistent Low Mood
Key Takeaways
- Depression originates from measurable disruptions in brain circuitry — not from personal weakness or a single “chemical imbalance.”
- Chronic stress dysregulates the HPA axis, flooding the brain with cortisol that physically shrinks the hippocampus and weakens prefrontal regulation over time.
- Serotonin transporter gene variants (5-HTTLPR) modulate stress sensitivity, but gene-environment interaction — not genetics alone — determines whether depression emerges.
- Prefrontal-amygdala connectivity deficits leave emotional responses under-regulated, producing the sustained negative affect characteristic of depressive states.
- Epigenetic stress markers alter gene expression without changing DNA, meaning early adversity can create lasting neurobiological vulnerability decades later.
- Neuroplasticity means these patterns are structurally modifiable — targeted intervention can restore hippocampal volume, normalize cortisol output, and rebuild prefrontal regulatory capacity.
Depression is driven by identifiable disruptions in neural architecture — dysregulated stress hormones, weakened prefrontal control over the amygdala, altered serotonin transporter function, and epigenetic changes that shift how genes express under pressure. These are not abstract concepts. They are measurable, mappable patterns in the brain that explain why someone feels persistently flat, unmotivated, or trapped in emotional states that logic alone cannot resolve. Understanding these specific mechanisms matters because each one responds to a different type of intervention. A cortisol-driven depression rooted in HPA axis overactivation requires a fundamentally different approach than one driven by prefrontal-amygdala disconnection or serotonin transporter inefficiency. MindLAB Neuroscience works at this level of specificity — identifying which neural patterns are actually producing the depressive state and addressing those patterns directly, rather than applying a generalized protocol that assumes all depression looks the same underneath.
How Does HPA Axis Dysregulation Cause Depression?
Chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis floods the brain with cortisol, progressively damaging the hippocampus and weakening the prefrontal cortex’s capacity to regulate emotional responses — creating the biological foundation for sustained depressive states. This is not a temporary chemical fluctuation; it is a structural erosion of the brain regions responsible for mood regulation, memory consolidation, and cognitive flexibility.
The HPA axis functions as the brain’s central stress-response system. When a perceived threat registers, the hypothalamus signals the pituitary gland, which triggers adrenal cortisol release. In acute stress, this cascade serves a protective function — heightening alertness, mobilizing energy, sharpening focus. The problem begins when the threat never fully resolves. Ongoing financial pressure, relational conflict, professional uncertainty, or the accumulated weight of managing complex obligations without adequate recovery — these sustained demands keep the HPA axis firing chronically, and cortisol levels remain elevated far beyond their useful window.
The downstream effects are concrete. Duman and Aghajanian (2012) demonstrated that chronic stress exposure produces measurable synaptic loss in the prefrontal cortex, reducing the number of functional connections between neurons in precisely the brain region responsible for executive control and emotional regulation. Hippocampal volume reductions — documented repeatedly in neuroimaging studies of individuals with recurrent depression — reflect cortisol-driven dendritic atrophy: the physical retraction of neuronal branches that weakens the hippocampus’s ability to contextualize emotional experience and distinguish past threat from present safety.
This explains a pattern that many people living with depression recognize intuitively: the sense that emotional reactions have become disconnected from their actual circumstances. A minor setback triggers a disproportionate collapse in mood. A neutral interaction reads as threatening. The prefrontal cortex — compromised by sustained cortisol exposure — can no longer provide the top-down modulation that keeps emotional responses proportional to their triggers. The result is not a mood problem in isolation. It is a regulatory architecture problem with mood as its most visible output.
What Role Do Serotonin Transporter Genetics Play in Depression?
Variations in the serotonin transporter gene (5-HTTLPR) alter how efficiently the brain recycles serotonin at the synapse, modulating an individual’s stress sensitivity — but genetics alone do not cause depression. The short allele variant creates heightened reactivity to environmental stressors, meaning the same life event produces a stronger neurochemical stress response in carriers than in those with the long allele.
The gene-environment interaction model, which has largely replaced the earlier “chemical imbalance” framing, explains why depression clusters in some families without following a simple hereditary pattern. A person carrying the short allele variant may move through decades of life without experiencing depression — until a specific constellation of stressors activates the vulnerability that was always present at the genetic level. Caspi and colleagues’ landmark 2003 study in Science established this interaction: individuals with the short allele who experienced significant life stress developed depression at markedly higher rates than those with the same genetic profile but lower stress exposure, or those with the long allele regardless of stress exposure.
What this means practically is that genetic vulnerability operates as a threshold modifier, not a deterministic switch. The serotonin transporter variant does not manufacture depression. It lowers the threshold at which environmental pressure tips the brain’s regulatory systems toward depressive states. This distinction matters enormously for intervention design. Addressing the genetic component alone — through medication that targets serotonin reuptake — misses the environmental and cognitive factors that activated the vulnerability. Addressing environmental stressors alone misses the underlying neurochemical sensitivity that made those stressors depressogenic in the first place.
Depression is not a single malfunction — it is a convergence of neural vulnerabilities meeting environmental pressure at a threshold the brain’s regulatory architecture can no longer absorb.
MindLAB’s approach accounts for both sides of this equation. When someone arrives carrying the neurochemical signature of heightened serotonergic sensitivity, the work involves identifying which specific environmental and cognitive patterns are repeatedly activating that vulnerability — and restructuring those patterns at the neural level so the brain stops cycling through the same stress-depression cascade.
How Does Prefrontal-Amygdala Disconnection Drive Depressive States?
Weakened functional connectivity between the prefrontal cortex and the amygdala reduces the brain’s capacity to downregulate threat responses and negative emotional states, leaving individuals neurologically locked into sustained patterns of sadness, rumination, and emotional flatness. This connectivity deficit is one of the most consistently replicated findings in depression neuroimaging research.
In a well-regulated brain, the prefrontal cortex acts as a governor over the amygdala’s reactivity. When the amygdala flags an experience as threatening or aversive, prefrontal circuits evaluate the signal, contextualize it, and — when appropriate — dampen the emotional response. This is not suppression. It is proportionality: the neural mechanism that allows a person to feel disappointment without spiraling into despair, or to register frustration without collapsing into hopelessness.
In depressive states, this regulatory circuit operates at reduced capacity. The amygdala fires — and the prefrontal cortex fails to modulate the signal effectively. The subjective experience is one that people with depression describe with remarkable consistency: emotions feel stuck. Negative states persist long after their trigger has passed. The ability to shift perspective, reframe a setback, or generate motivational drive toward action becomes profoundly diminished — not because of insufficient willpower, but because the neural hardware supporting those functions is operating below its design threshold.
Harmer and Duman (2024) demonstrated that cognitive changes — shifts in attentional bias, threat appraisal, and information processing patterns — precede mood improvements during recovery from depression, suggesting that restoring prefrontal regulatory function is the mechanism through which subjective mood actually shifts. This finding has direct implications for how depression should be addressed: interventions that rebuild prefrontal-amygdala connectivity produce more durable results than those targeting mood symptoms in isolation.
This is where the specificity of a neuroscience-guided approach produces measurably different outcomes. Rather than attempting to override emotional states through willpower or surface-level behavioral strategies, the work targets the actual connectivity deficit — strengthening the prefrontal circuits that govern emotional regulation through structured, repeated activation during emotionally charged real-world moments when the brain is most plastic.
Can Childhood Adversity Permanently Alter the Brain’s Vulnerability to Depression?
Early adverse experiences — neglect, chronic household stress, attachment disruption, or loss — physically reshape the developing brain’s stress-response architecture during critical periods, creating measurable neurobiological vulnerability to depression that can persist for decades. This is not metaphorical. Epigenetic modifications alter how genes express without changing the underlying DNA sequence, effectively embedding early experience into the brain’s operating code.
The mechanism operates through methylation and histone modification — chemical processes that determine which genes activate and which remain silent. Chronic early stress produces epigenetic changes to the glucocorticoid receptor gene (NR3C1), reducing the brain’s capacity to regulate its own cortisol response. The result is an HPA axis that runs hotter than it should — overproducing cortisol in response to moderate stressors, underperforming at the recovery phase, and gradually eroding the hippocampal and prefrontal structures described in the sections above.
van der Kolk’s extensive research on developmental trauma established that adverse childhood experiences produce lasting changes in both brain structure and function, with the amygdala maintaining heightened threat sensitivity long after the threatening environment has changed. Children who grew up in chronically stressful environments develop amygdalae that are — measurably, on imaging — more reactive and harder to downregulate than those of peers who did not experience similar adversity.
The accumulation model adds an additional dimension. A single adverse event during childhood is less predictive of adult depression than the accumulation of multiple smaller stressors over time. Chronic unpredictability, emotional inconsistency from caregivers, or sustained exposure to conflict shapes the developing brain more profoundly than a single traumatic incident — because the developing nervous system adapts its baseline architecture to match the environment it expects to inhabit long-term.
The critical insight here is that “permanently” is the wrong framing, despite the real and lasting nature of these changes. Epigenetic modifications are, by their nature, reversible. The same plasticity that allowed early stress to reshape the brain’s architecture means that targeted intervention can reshape it again. The neural patterns are deeply grooved, but they are not fixed. This is precisely the domain where neuroscience-informed work produces outcomes that conventional approaches struggle to match — because the work must operate at the level of the embedded pattern, not the surface-level symptoms it generates.
Why Does Depression Often Co-Occur with Anxiety, Insomnia, and Chronic Pain?
Depression rarely presents in isolation because the neural circuits it disrupts — HPA axis regulation, prefrontal executive function, serotonergic and dopaminergic signaling — are shared infrastructure that also governs anxiety responses, sleep architecture, and pain perception. Comorbidity is not coincidence; it is a predictable consequence of overlapping neural disruption.
The prefrontal-amygdala circuit that weakens in depression is the same circuit that fails to downregulate the exaggerated threat perception characteristic of anxiety and its neural underpinnings. The HPA axis dysregulation that drives cortisol-mediated hippocampal damage also disrupts the circadian cortisol rhythm that governs sleep onset and sleep maintenance. The serotonergic deficits implicated in depressive mood also modulate the brain’s pain-gating mechanisms in the periaqueductal gray and dorsal raphe nucleus — which explains the otherwise puzzling clinical observation that people with depression frequently report heightened physical pain sensitivity.
This convergence creates a reinforcement loop that makes depression particularly resistant to single-modality intervention. Poor sleep elevates cortisol, which worsens prefrontal function, which reduces emotional regulation capacity, which intensifies both depressive and anxious states, which further disrupts sleep. Chronic pain activates stress circuits that compound HPA axis dysregulation. Anxiety-driven avoidance behaviors reduce exposure to the social and environmental inputs that the brain requires for neuroplastic recovery.
Understanding comorbidity as shared-circuit disruption rather than as separate conditions that happen to overlap changes the intervention calculus entirely. Addressing depression while leaving the anxiety, sleep, or pain circuits untouched leaves the reinforcement loop intact — and relapse becomes a matter of when, not whether. MindLAB’s neuroscience-guided model maps the full circuit disruption pattern for each individual, because the specific combination of affected circuits determines which intervention sequence will actually produce durable change.
The brain does not partition its dysfunction into neat diagnostic categories — it disrupts shared circuits, and the cascade produces whichever combination of symptoms those circuits govern.
How Do Lifestyle Factors Interact with Neurobiological Vulnerability?
Sleep deprivation, sedentary behavior, and nutritional deficiency do not cause depression independently, but they systematically degrade the neural infrastructure that protects against depressive states — weakening prefrontal function, elevating baseline cortisol, and reducing the brain-derived neurotrophic factor (BDNF) levels required for synaptic maintenance and repair.
Sleep is the most potent modulator. During slow-wave sleep, the glymphatic system clears metabolic waste from the brain, cortisol levels reset to baseline, and memory consolidation processes — including emotional memory reconsolidation — perform their maintenance functions. Chronic sleep restriction (consistently fewer than six hours) produces prefrontal hypofunction that closely mirrors the connectivity deficits observed in clinical depression. The individual does not need a genetic predisposition or a traumatic history to develop depressive symptoms under sustained sleep deprivation — the mechanism operates through direct neural degradation.
Physical activity produces BDNF release — the protein most directly responsible for neuronal growth, synaptic strengthening, and hippocampal neurogenesis. Regular aerobic exercise has demonstrated antidepressant effects comparable to pharmacological intervention in mild-to-moderate depression, and the mechanism is now well-characterized: BDNF-mediated synaptic proliferation in the hippocampus and prefrontal cortex partially reverses the dendritic atrophy caused by chronic cortisol exposure. Sedentary patterns remove this protective input, allowing stress-driven neural erosion to proceed unchecked.
Nutritional factors operate through multiple pathways. Tryptophan — the amino acid precursor to serotonin — requires dietary intake; deficiency directly limits serotonergic capacity. Omega-3 fatty acids maintain neuronal membrane integrity and modulate inflammatory signaling in the brain. Chronic inflammation, increasingly recognized as a contributor to depressive states, responds to both dietary intervention and the anti-inflammatory effects of regular physical activity.
None of these factors exist in isolation. A person carrying serotonin transporter vulnerability who also sleeps poorly, exercises rarely, and maintains a diet low in tryptophan and omega-3s is stacking neurobiological risk factors — each one lowering the threshold at which environmental stress tips the system into a depressive state. Conversely, optimizing these modifiable factors raises that threshold measurably, providing the neurobiological buffer that makes the brain more resilient to the stressors that cannot be eliminated.
Can Neuroplasticity Reverse the Neural Patterns That Cause Depression?
Neuroplasticity — the brain’s capacity to reorganize its structure and function in response to experience — means the neural patterns underlying depression are modifiable, not permanent. Research demonstrates that targeted intervention can increase hippocampal volume, restore prefrontal-amygdala connectivity, normalize HPA axis function, and even reverse epigenetic stress markers.
Duman and Aghajanian (2012) showed that synaptic connections lost in the prefrontal cortex during depression can be restored — in some cases within hours — through interventions that activate the mTOR signaling pathway responsible for synaptogenesis. This finding demolished the older view that depression-related brain changes were degenerative and irreversible. The synapses are not destroyed; they are retracted. And retracted connections can regrow when the right conditions are established.
The practical question is not whether the brain can change — decades of research have settled that conclusively — but under what conditions change occurs most efficiently. Neuroplasticity is not uniformly active. It peaks during states of heightened emotional arousal, focused attention, and novel experience. This is the scientific basis for Real-Time Neuroplasticity™ — the principle that neural restructuring is most effective when it occurs during the live emotional moments that activate the problematic circuits, rather than during retrospective conversation about those moments after the plasticity window has closed.
For someone whose depression is rooted in HPA axis dysregulation from chronic stress, neuroplastic intervention targets the cortisol-response cascade in real time — restructuring the appraisal patterns that trigger the cascade, building prefrontal inhibitory capacity over the stress response, and gradually recalibrating the HPA axis toward a lower baseline. For someone whose depression reflects prefrontal-amygdala disconnection, the work rebuilds that specific connectivity through structured emotional regulation practice during moments of genuine emotional activation.
This specificity is what distinguishes neuroscience-guided intervention from generalized approaches. Depression is not one condition with one cause and one solution. It is a convergence of disrupted neural patterns — each one identifiable, each one addressable, and each one requiring an intervention matched to its specific mechanism. The brain built these patterns. Given the right conditions, it can rebuild them.
- Duman, R. S. and Aghajanian, G. K. (2012). Synaptic dysfunction in depression: Potential therapeutic targets. Science, 338(6103), 68–72. https://doi.org/10.1126/science.1222941
- Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A. and Poulton, R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386–389. https://doi.org/10.1126/science.1083968
- Harmer, C. J. and Duman, R. S. (2024). Cognitive precursors to mood recovery: Neural circuit perspectives. Molecular Psychiatry, 29(3), 412–428. https://doi.org/10.1038/s41380-023-02345-7
- van der Kolk, B. A. (2014). The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. Viking. https://pubmed.ncbi.nlm.nih.gov/25784053/
- McEwen, B. S. (2017). Neurobiological and systemic effects of chronic stress. Chronic Stress, 1, 1–11. https://doi.org/10.1177/2470547017692328
- Meaney, M. J. (2001). Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annual Review of Neuroscience, 24, 1161–1192. https://doi.org/10.1146/annurev.neuro.24.1.1161
What the First Conversation Looks Like
Most people who reach out to MindLAB Neuroscience have already spent years trying to resolve what they are experiencing — and nothing has produced lasting change. The first conversation is not a repeat of that cycle. It is a structured assessment of what is actually happening in the brain: which circuits are disrupted, which stress-response patterns are driving the depressive state, and which specific mechanisms need to change for the depression to resolve durably rather than temporarily. Dr. Ceruto typically identifies the root neural pattern within the first one or two conversations — often a fundamentally different issue than the one the person initially presents. That clarity alone shifts the trajectory, because for the first time, there is a specific target rather than a vague diagnosis. If the neuroscience suggests the work is a fit, the next steps are concrete and immediate.